Welcome to our dedicated page for Paychex SEC filings (Ticker: PAYX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Paychex, Inc. filings document formal disclosures for its human capital management business, including quarterly operating results furnished on Form 8-K, credit facility amendments, capital-return authorizations, and governance changes involving directors and senior officers.
The company's proxy materials and annual-meeting reports address board elections, executive compensation votes, auditor ratification, committee matters, and stockholder voting outcomes. Its filings also describe common-stock repurchase authority, revolving credit facilities, covenant changes, and formal reporting for payroll, HCM, HR Solutions, PEO, ASO, benefits, retirement, and insurance services.
Paychex (PAYX) insider reported a charitable gift of common stock. On 10/28/2025, the reporting person executed a Code G transaction, gifting 200 shares at $123.87 per share. Following the transaction, the filer beneficially owns 36,640,384 shares directly and 41,277 shares indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dtd 6/13/2005. The filer is identified as a Director and filed individually.
Paychex (PAYX) director reported a charitable transfer of common stock. On 10/22/2025, the insider filed a Code G transaction indicating a gift of 302,050 shares to various non-profit organizations.
After the transaction, the filer reported 36,640,584 shares beneficially owned directly and 41,277 shares owned indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dtd 6/13/2005.
Paychex Inc. (PAYX) reported an insider Form 4 for a senior vice president. On 10/15/2025, the officer disposed of 41 common shares at $127.52 under code F, which indicates shares were withheld to cover taxes from vested restricted stock units.
After the transaction, the officer beneficially owned 9,794 shares, held directly. The filing also lists vested and unvested stock options, including 12,164 shares at an exercise price of $120.86 (expiring 07/14/2033) and 14,291 shares at $121.63 (expiring 07/14/2034).
Paychex (PAYX) reported an insider equity award on Form 4. A director acquired 725 shares of common stock via restricted stock units on 10/15/2025 at $0, increasing beneficial ownership to 79,344 shares directly.
The filing also shows a new stock option grant for 3,061 shares at an exercise price of $127.52 on 10/15/2025, first exercisable on 10/15/2026 and expiring on 10/14/2035. Existing option holdings remain outstanding across multiple grants, with exercise prices ranging from $57.20 to $140.68 and expirations extending through 2035. The RSU award is pursuant to the Amended and Restated 2002 Stock Incentive Plan.
Paychex, Inc. (PAYX) disclosed an insider equity award. A director reported acquiring 725 shares of common stock on 10/15/2025 at $0, reflecting vested or granted shares. Following the transaction, the director beneficially owned 11,770 shares directly.
The filer also received a stock option grant for 3,061 shares at an exercise price of $127.52, exercisable 10/15/2026 and expiring 10/14/2035. The filing notes the equity award includes restricted stock units subject to vesting under the company’s Amended and Restated 2002 Stock Incentive Plan.
Paychex (PAYX) reported an insider transaction by its Sr. VP & CFO. On 10/15/2025, the officer disposed of 116 shares of common stock at $127.52 under code F, a sale to cover taxes from the vesting of restricted stock units. Following the transaction, the officer beneficially owns 19,165 shares directly and 322 shares indirectly via a 401(k). The filing also lists outstanding stock options across multiple grants with various exercise prices and expirations.
Paychex (PAYX) disclosed a director’s equity awards on Form 4. The reporting person acquired 725 shares of common stock at $0, noted as restricted stock units subject to vesting. The filing also reports a new stock option grant for 3,061 shares at $127.52 on 10/15/2025, exercisable 10/15/2026 and expiring 10/14/2035. Following the transaction, 3,951 shares of common stock were beneficially owned directly.
Paychex (PAYX) filed a Form 3 reporting initial beneficial ownership by an officer. As of the event date 10/09/2025, the reporting person, an SVP, HCM, PEO & Insurance, directly owns 6,683 shares of Common Stock.
Table II lists stock options for Common Stock as follows: 6,775 shares at $119.72 exercisable on 01/15/2025 expiring 01/14/2034; 13,192 shares at $121.63 exercisable on 07/15/2025 expiring 07/14/2034; and 11,813 shares at $140.68 exercisable on 07/15/2026 expiring 07/14/2035. The filing indicates direct ownership and was signed by an attorney-in-fact.
Paychex (PAYX) reported an insider equity award on a Form 4. A director acquired 725 shares of common stock on 10/15/2025 at $0, noted as an award of restricted stock units subject to vesting under the Amended and Restated 2002 Stock Incentive Plan. Following the transaction, the insider beneficially owned 20,504 shares, held directly.
The filing also lists a new stock option grant for 3,061 shares at an exercise price of $127.52 on 10/15/2025, exercisable 10/15/2026 and expiring 10/14/2035. Additional previously granted options with various strike prices and expirations remain outstanding.
Paychex (PAYX) — Form 4 insider activity: A company director reported equity awards dated 10/15/2025. The filing shows 725 shares of common stock acquired at $0, reflecting settlement of restricted stock units under the Amended and Restated 2002 Stock Incentive Plan. Following this, beneficial ownership stands at 67,364 shares, held directly.
The director also reported a new stock option grant for 3,061 shares at an exercise price of $127.52, granted on 10/15/2025, exercisable starting 10/15/2026 and expiring on 10/14/2035. The filing lists additional previously granted options with exercise prices and expirations on a rolling schedule.